Lantern Pharma Inc.
LTRNNasdaqCIK 1763950HealthcareFiscal year ends Dec 31
Reports and events: 106 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1920:15 ET | DEF 14A | Proxy statementPeriod 2026-10-19 | 0001493152-26-047586 |
| 2026-10-0120:01 ET | 8-K | 3.01 Delisting notice | 0001493152-26-045344 |
| 2026-09-3020:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-045100 |
| 2026-09-2400:41 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-044007 |
| 2026-09-2311:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-043808 |
| 2026-08-1411:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037979 |
| 2026-08-1411:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037971 |
| 2026-08-0321:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035864 |
| 2026-06-1220:30 ET | S-1 | Registration statement | 0001493152-26-028460 |
| 2026-06-0223:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-026696 |
| 2026-05-1520:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001813314-26-000008 |
| 2026-05-1520:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-023758 |
| 2026-05-1520:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023740 |
| 2026-05-1421:26 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-023200 |
| 2026-04-3010:05 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001493152-26-019713 |
| 2026-04-1619:48 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001813314-26-000005 |
| 2026-04-1012:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-016047 |
| 2026-03-3021:36 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-013612 |
| 2026-03-3021:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-013608 |
| 2026-02-2321:37 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001813314-26-000002 |
| 2026-01-2312:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-003314 |
| 2025-11-1313:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-022134 |
| 2025-11-1221:17 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021927 |
| 2025-09-2320:45 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-014652 |
| 2025-08-1320:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023489 |
| 2025-08-1320:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023471 |
| 2025-08-0821:17 ET | DEF 14A | Proxy statementPeriod 2025-08-08 | 0001641172-25-022820 |
| 2025-07-2921:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-021407 |
| 2025-07-0320:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-017810 |
| 2025-06-1323:43 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-059524 |
| 2025-05-1512:35 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010547 |
| 2025-05-1512:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-010541 |
| 2025-04-3000:56 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001641172-25-006728 |
| 2025-03-2720:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-000926 |
| 2025-03-2720:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-000917 |
| 2025-01-1021:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-001685 |
| 2024-11-0802:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-044124 |
| 2024-11-0721:07 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-044010 |
| 2024-11-0721:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044006 |
| 2024-08-0820:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-030766 |
| 2024-08-0820:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-030764 |
| 2024-06-1720:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-024110 |
| 2024-05-2420:09 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-021353 |
| 2024-05-0920:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-018422 |
| 2024-05-0920:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-018426 |
| 2024-04-2911:30 ET | DEF 14A | Proxy statementPeriod 2024-04-29 | 0001493152-24-016840 |
| 2024-03-1820:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-010302 |
| 2024-03-1820:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-010303 |
| 2024-03-0121:10 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-029971 |
| 2023-12-2921:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-23-046572 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.